What does a reverse T3 (rT3) level indicate?

What Reverse T3 (rT3) Means

Reverse T3 is a biologically inactive metabolite of thyroid hormone that has no established clinical utility in routine thyroid disease management and should not be routinely measured.

Biochemistry and Formation

Reverse T3 (3',5'-triiodothyronine) is produced when the thyroid prohormone thyroxine (T4) undergoes inner ring deiodination by type 1 and type 3 deiodinase enzymes (D1 and D3), creating an inactive isomer rather than the active hormone T3 1. This represents a metabolic shunt that diverts T4 away from active T3 production 2, 1. Unlike T3, which binds strongly to nuclear thyroid hormone receptors to regulate gene transcription, rT3 binds only weakly and lacks agonist activity 1, 3.

Clinical Contexts Where rT3 Rises

Non-Thyroidal Illness Syndrome

• Severe acute illness causes marked elevation of rT3 alongside suppression of T3, a pattern historically termed "euthyroid sick syndrome" 2, 1.
• In acute myocardial infarction, rT3 levels above 0.41 nmol/L were associated with 3-fold increased 1-year mortality (hazard ratio 3.0,95% CI 1.4–6.3), independent of other cardiac risk factors 4.
• In advanced heart failure, a low free T3/rT3 ratio predicted poor 6-week outcome better than any other marker, with 1-year survival of 100% for normal ratios versus 37% for low ratios 5.

Medications

• Amiodarone inhibits rT3 metabolism, causing accumulation of rT3 in serum 1.

Levothyroxine Therapy

• Patients taking levothyroxine (T4) alone had the highest rate of elevated rT3 (20.9%) compared to 9% in untreated patients 2.
• All forms of T4-containing therapy produced higher rT3 levels than no treatment (p<0.00001), with rT3 correlating positively with free T4 levels 2.
• Preparations containing T3 (liothyronine) resulted in lower rT3 levels 2.

Why rT3 Testing Is Not Recommended

No professional thyroid guidelines recommend routine rT3 measurement 6. The reasons are compelling:

• Lack of diagnostic specificity: Elevated rT3 occurs in numerous conditions (critical illness, medications, stress, inflammation) and does not distinguish between them 1, 3.
• No treatment implications: There is no evidence that treating elevated rT3 improves outcomes, and professional endocrinology societies do not recognize "high rT3" as a treatable condition 6.
• Inappropriate ordering patterns: A review found 55% (11/20) of rT3 orders were clinically inappropriate, and inappropriate orders were less likely to have endocrinologist involvement 6.
• Functional medicine misuse: Despite lack of peer-reviewed evidence, some practitioners prescribe T3-only preparations based solely on rT3 levels in patients with otherwise normal thyroid function 2, 6.

The "Functional Hypothyroidism" Hypothesis

Some propose that elevated rT3 creates "functional hypothyroidism" by competitively blocking T3 at receptor sites, even when TSH and T4 are normal 3. This theory suggests increased D3 activity during stress shifts metabolism toward inactive rT3, reducing intracellular T3 action 3. Elevated rT3 and reduced T3/rT3 ratios have been reported in depression, bipolar disorder, anxiety, and cognitive impairment 3.

However, this remains a hypothesis without validation in clinical trials or guideline endorsement 6. The weak receptor binding of rT3 makes significant competitive inhibition unlikely at physiologic concentrations 1.

When rT3 Might Have Limited Diagnostic Value

• Genetic deiodinase disorders: rT3 measurement can provide a diagnostic fingerprint for rare genetic conditions affecting iodothyronine deiodinases, thyroid transporters, or binding proteins 1.
• Prognostic marker in critical illness: In acute MI or heart failure, rT3 elevation identifies high-risk patients, though this does not change acute management 4, 5.

Critical Pitfalls

• Do not order rT3 to evaluate persistent symptoms in patients on adequate levothyroxine replacement (normal TSH, normal free T4). Approximately 15% of such patients report fatigue, but rT3 testing does not guide management 2, 6.
• Do not switch patients to T3-only therapy based on elevated rT3 alone. This practice lacks evidence and can cause iatrogenic hyperthyroidism 6.
• Consult endocrinology before ordering rT3. Inappropriate orders are common when specialists are not involved 6.

Practical Recommendation

For patients with persistent hypothyroid symptoms despite normal TSH on levothyroxine, focus on:

• Confirming medication adherence and proper timing (30–60 minutes before food) 7
• Excluding malabsorption, drug interactions, or inadequate dosing 7
• Evaluating alternative causes of fatigue (anemia, sleep disorders, depression, vitamin deficiencies) 7
• Considering a trial of combination T4/T3 therapy in select cases, but not based on rT3 levels 7

Trust your endocrinologist—rT3 testing rarely changes management and often leads to inappropriate treatment 6.